Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
2050.00Today’s High
2111.0052W low
1075.0052W High
2111.00Open Price
2050.00Prev. Close
1823.0000Volume
69163.00Value
143793335.15Fundamentals
Market Cap Cr
19952.80
Price to Earnings
77.30
Price to Book Value
13.60
Dividend Yield
0.10
PE to Growth
1.80
Op Revenue TTM Cr
1375.80
Net Profit TTM Cr
258.26
Cash From Operating Activity Cr
266.08
Return on Equity %
17.56
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
43
Week
51
Month
77.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
2025.77
PIVOT
First Resistance
2100.53
Second Resistance
2152.67
Third Resistance
2227.43
First Support
1973.63
Second Support
1898.87
Third Support
1846.73
Relative Strength Index
64.8
Money Flow Index
82.94
MACD
59.34
MACD Signal
65.09
Average True Range
79.38
Average Directional Index
32.88
Rate of Change (21)
19.87
Rate of Change (125)
42.38
Commodity Channel Index
85.3
Williams %R
-20
BETA
1 Month
0.74
3 Month
0.51
1 Year
0.59
3 Year
0.21
PRICE CHANGE ANALYSIS
↑ 6.74%
1 Week
Low
High
1922.95
2111
↑ 21.67%
1 Month
Low
High
1655.15
2111
↑ 32.26%
3 Months
Low
High
1488.6
2111
↑ 44.89%
6 Months
Low
High
1361
2111
↑ 80.85%
1 Year
Low
High
1075
2111
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 376.59 | 337.43 | 332.68 | 318.73 | 301.97 | 286.09 | 272.69 | 243.58 | 253.44 | 227.22 | 224.22 | |
| Operating Expenses Qtr | 263.52 | 236.46 | 237.29 | 220.46 | 211.64 | 203.42 | 197.71 | 190.80 | 187.59 | 169.16 | 161.48 | |
| Operating Profit Qtr | 97.40 | 84.40 | 82.60 | 85.10 | 81.68 | 68.32 | 66.28 | 48.20 | 56.85 | 50.89 | 50.46 | |
| EBIDT Qtr Cr | 113.06 | 100.97 | 95.39 | 98.27 | 90.33 | 82.67 | 74.99 | 52.78 | 65.85 | 58.06 | 62.75 | |
| Depreciation Qtr | 16.16 | 15.53 | 15.33 | 15.04 | 14.71 | 13.62 | 13.72 | 13.58 | 13.53 | 13.27 | 13.19 | |
| Net Profit Qtr | 70.53 | 61.46 | 59.21 | 60.52 | 57.48 | 47.54 | 45.22 | 28.80 | 38.44 | 34.21 | 37.34 | |
| Basic EPS Qtr | 7.35 | 6.41 | 6.17 | 6.31 | 6.00 | 4.95 | 4.72 | 3.00 | 4.01 | 3.57 | 3.89 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1365.43 | 1104.33 | 918.09 | 766.67 | 664.75 | |
| Operating Expenses Annual Cr | 957.74 | 803.57 | 667.22 | 539.06 | 486.02 | |
| Operating Profit Annual | 349.51 | 264.48 | 212.13 | 208.32 | 160.14 | |
| Operating Profit Margin Annual % | 25.60 | 23.95 | 23.11 | 27.17 | 24.09 | |
| Total Expenses Annual Cr | 1030.53 | 867.51 | 723.37 | 593.29 | 542.96 | |
| EBIDT Annual Cr | 407.69 | 300.76 | 250.86 | 227.61 | 178.72 | |
| EBIDT Annual margin % | 29.86 | 27.23 | 27.32 | 29.69 | 26.89 | |
| Depreciation | 62.05 | 55.64 | 52.54 | 46.31 | 39.28 | |
| PAT Before ExtraOrdinary Items Annual Cr | 251.72 | 179.04 | 146.02 | 129.51 | 92.38 | |
| Net Profit Annual | 251.72 | 179.04 | 146.02 | 129.51 | 92.38 | |
| Basic EPS Annual | 26.24 | 18.67 | 15.23 | 14.54 | 10.47 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1458.25 | 1234.12 | 1076.97 | 954.01 | 429.28 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 35.57 | 34.69 | 53.72 | 81.41 | 134.50 | |
| Total Current Liabilities Annual Cr | 327.53 | 268.95 | 203.27 | 151.99 | 176.17 | |
| Total Capital Plus Liabilities Annual Cr | 1821.35 | 1537.76 | 1333.96 | 1187.41 | 739.95 | |
| Fixed Assets Annual | 898.40 | 676.07 | 494.30 | 410.67 | 352.20 | |
| Total Non Current Assets Annual | 1029.57 | 782.18 | 592.97 | 512.06 | 446.65 | |
| Total Current Assets Annual | 791.78 | 755.58 | 740.99 | 675.35 | 293.31 | |
| Total Assets Annual | 1821.35 | 1537.76 | 1333.96 | 1187.41 | 739.95 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 163.99 | 169.58 | 99.20 | 114.49 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 256.10 | 194.86 | 126.26 | 116.40 | 126.91 | |
| Cash from Investing Activity Annual | -237.02 | -187.22 | -88.71 | -434.41 | -105.67 | |
| Cash from Financing Annual Activity | -17.32 | -7.89 | -39.71 | 318.92 | -22.25 | |
| Net Cash Flow Annual | - | -0.25 | -2.16 | 0.90 | -1.02 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 151.95 | 128.63 | 112.30 | 99.50 | 48.65 | |
| ROE Annual % | 17.26 | 14.50 | 13.55 | 13.57 | 21.52 | |
| ROCE Annual % | 23.13 | 19.31 | 17.53 | 17.50 | 24.73 | |
| Total Debt to Total Equity Annual | 0.11 | 0.11 | 0.10 | 0.10 | 0.36 | |
| EBDIT Annual Margin % | 31.18 | 28.16 | 28.52 | 30.45 | 27.65 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 393.05 | 356.17 | 351.39 | 333.94 | 315.35 | 299.26 | 283.38 | 253.42 | 265.71 | 237.41 | 235.63 | |
| Operating Expenses Qtr | 281.49 | 249.38 | 253.07 | 233.64 | 223.64 | 213.81 | 210.01 | 202.38 | 201.77 | 179.09 | 172.50 | |
| Operating Profit Qtr | 96.58 | 90.22 | 84.23 | 87.19 | 83.21 | 71.02 | 64.68 | 46.47 | 55.75 | 51.19 | 50.87 | |
| EBIDT Qtr Cr | 111.78 | 107.50 | 99.16 | 101.06 | 91.71 | 85.45 | 73.37 | 51.04 | 63.94 | 58.32 | 63.13 | |
| Depreciation Qtr | 16.20 | 16.21 | 15.99 | 15.52 | 14.79 | 14.19 | 14.25 | 13.93 | 13.99 | 13.59 | 13.50 | |
| Net Profit Qtr | 68.36 | 65.02 | 62.19 | 62.70 | 58.81 | 50.01 | 43.50 | 26.96 | 36.17 | 34.51 | 38.23 | |
| Basic EPS Qtr | 7.12 | 6.78 | 6.48 | 6.54 | 6.13 | 5.21 | 4.53 | 2.81 | 3.77 | 3.60 | 3.99 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1434.54 | 1151.42 | 960.97 | 804.88 | 705.70 | |
| Operating Expenses Annual Cr | 1017.57 | 849.85 | 709.96 | 572.11 | 523.28 | |
| Operating Profit Annual | 358.22 | 265.38 | 213.10 | 214.36 | 163.96 | |
| Operating Profit Margin Annual % | 24.97 | 23.05 | 22.18 | 26.63 | 23.23 | |
| Total Expenses Annual Cr | 1092.80 | 915.85 | 768.17 | 628.14 | 582.12 | |
| EBIDT Annual Cr | 416.97 | 301.57 | 251.00 | 232.78 | 182.42 | |
| EBIDT Annual margin % | 29.07 | 26.19 | 26.12 | 28.92 | 25.85 | |
| Depreciation | 63.93 | 57.17 | 53.95 | 47.52 | 40.53 | |
| PAT Before ExtraOrdinary Items Annual Cr | 258.26 | 177.36 | 144.06 | 132.56 | 93.74 | |
| Net Profit Annual | 258.26 | 179.28 | 146.51 | 135.87 | 95.88 | |
| Basic EPS Annual | 26.90 | 18.69 | 15.28 | 15.24 | 10.86 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1470.05 | 1241.63 | 1087.48 | 965.57 | 434.82 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 37.38 | 42.28 | 62.68 | 86.76 | 135.39 | |
| Total Current Liabilities Annual Cr | 351.24 | 293.30 | 226.68 | 171.40 | 197.11 | |
| Total Capital Plus Liabilities Annual Cr | 1858.67 | 1577.21 | 1376.83 | 1223.73 | 767.32 | |
| Fixed Assets Annual | 910.80 | 684.84 | 502.91 | 418.37 | 359.07 | |
| Total Non Current Assets Annual | 1017.05 | 770.20 | 593.40 | 517.95 | 449.54 | |
| Total Current Assets Annual | 841.63 | 807.01 | 783.44 | 705.78 | 317.79 | |
| Total Assets Annual | 1858.67 | 1577.21 | 1376.83 | 1223.73 | 767.32 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 163.99 | 169.58 | 99.20 | 106.94 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 266.08 | 190.83 | 123.47 | 118.73 | 130.50 | |
| Cash from Investing Activity Annual | -240.94 | -179.02 | -85.33 | -435.58 | -109.46 | |
| Cash from Financing Annual Activity | -20.15 | -12.51 | -35.34 | 316.95 | -20.51 | |
| Net Cash Flow Annual | - | -0.69 | 2.80 | 0.10 | 0.54 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 153.18 | 129.41 | 113.40 | 100.71 | 49.27 | |
| ROE Annual % | 17.56 | 14.43 | 13.47 | 14.07 | 22.04 | |
| ROCE Annual % | 23.42 | 19.03 | 17.13 | 17.60 | 24.88 | |
| Total Debt to Total Equity Annual | 0.12 | 0.12 | 0.12 | 0.11 | 0.39 | |
| EBDIT Annual Margin % | 30.30 | 27.04 | 27.19 | 29.59 | 26.54 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SMALLCAP WORLD FUND, INC | 2.26 | 74553547 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| RISHI BAID | 10.18 | 74553515 | 0 | 0 |
| HIMANSHU BAID | 8.24 | 74553516 | 0 | 0 |
| HIMANSHU BAID (HUF) | 4 | 74553517 | 0 | 0 |
| SMT.MUKULIKA BAID | 3.19 | 74553518 | 0 | 0 |
| RISHI BAID (HUF) | 2.9 | 74553519 | 0 | 0 |
| JUGAL KISHORE BAID | 2.38 | 74553520 | 0 | 0 |
| VISHAL BAID | 1.75 | 74553521 | 0 | 0 |
| SHAILY BAID | 1.24 | 74553522 | 0 | 0 |
| SHIREEN BAID | 1.17 | 74553523 | 0 | 0 |
| NEHA BAID | 1.07 | 74553524 | 0 | 0 |
| ZETTA MATRIX CONSULTING LLP | 8.67 | 74553530 | 0 | 0 |
| VCB TRADING LLP | 3.69 | 74553531 | 0 | 0 |
| JAI POLYPAN PVT. LTD. | 3.49 | 74553532 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| UTI - HEALTHCARE FUND | 2.25 | 74553539 |
| QUANT MUTUAL FUND - QUANT CONSUMPTION FUND | 2.12 | 74553540 |
| LIGHTHOUSE INDIA III EQUITY INVESTORS LIMITED | 2.94 | 74553546 |
| SMALLCAP WORLD FUND, INC | 2.26 | 74553547 |
| MAX LIFE INSURANCE CO. LTD. - PURE GROWTH FUND | 1.12 | 74553542 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| NIRMALA VINODKUMAR DAGA | 2.18 | 74553556 |
| VARUN DAGA | 1.62 | 74553557 |
| SHREANS DAGA | 1.53 | 74553558 |
| EZEKIEL GLOBAL BUSINESS SOLUTIONS LLP | 12.88 | 74553553 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 21, 2023 | 3 | FINAL | - | Equity Share |
| Sep 16, 2022 | 2.5 | FINAL | - | Equity Share |
| Sep 16, 2021 | 2.5 | FINAL | - | Equity Share |
| Feb 27, 2020 | 2 | INTERIM | Feb 29, 2020 | Equity Share |
| Sep 13, 2019 | 2 | FINAL | - | Equity Share |
| Sep 18, 2018 | 2 | FINAL | - | Equity Share |
| Sep 20, 2017 | 0.5 | FINAL | - | Equity Share |
| Feb 15, 2017 | 1 | INTERIM | Feb 16, 2017 | Equity Share |
| Nov 11, 2016 | 1 | INTERIM | Nov 15, 2016 | Equity Share |
| Sep 19, 2016 | 0.5 | FINAL | - | Equity Share |
| Mar 17, 2016 | 2.5 | INTERIM | Mar 18, 2016 | Equity Share |
| Sep 18, 2015 | 2.5 | FINAL | - | Equity Share |
| Sep 15, 2014 | 4 | FINAL | - | Equity Share |
| Sep 19, 2013 | 2 | FINAL | - | Equity Share |
| Sep 13, 2012 | 3 | FINAL | - | Equity Share |
| Aug 25, 2011 | 3 | FINAL | - | Equity Share |
| Aug 24, 2010 | 2.5 | FINAL | - | Equity Share |
| Aug 21, 2009 | 2.5 | FINAL | - | Equity Share |
| Aug 23, 2007 | 2.5 | FINAL | - | Equity Share |
| Aug 24, 2006 | 2 | FINAL | - | Equity Share |
| Sep 06, 2005 | 1.8 | FINAL | - | Equity Share |
| Sep 08, 2004 | 1.5 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Feb 02, 2015 | 10:5 | - |
| Ex-Date | Purpose | Notes |
|---|---|---|
| Jun 29, 2024 | Others | - |
| May 17, 2024 | Audited Results & Final Dividend | - |
| Mar 08, 2024 | Others | Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). |
| Jan 31, 2024 | Quarterly Results | - |
| Nov 04, 2023 | Quarterly Results | - |
| Aug 07, 2023 | Quarterly Results | - |
| May 09, 2023 | Audited Results & Final Dividend | - |
| Jan 28, 2023 | Quarterly Results | - |
| Nov 04, 2022 | Quarterly Results | - |
| Aug 04, 2022 | Quarterly Results | - |
| May 24, 2022 | Audited Results & Final Dividend | - |
| Jan 31, 2022 | Quarterly Results | - |
| Nov 01, 2021 | Quarterly Results | - |
| Jul 29, 2021 | Quarterly Results | - |
| May 24, 2021 | Audited Results & Dividend | - |
| Jan 27, 2021 | Quarterly Results | - |
| Dec 08, 2020 | Others | inter alia, to consider and approve the proposal of fund raising by way of debts, equity shares on preferential basis/private placement basis. |
| Oct 26, 2020 | Quarterly Results | - |
| Jul 30, 2020 | Quarterly Results | - |
| Jun 05, 2020 | Audited Results & Final Dividend | - |
| Feb 18, 2020 | Interim Dividend | - |
| Feb 01, 2020 | Quarterly Results | - |
| Nov 09, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 10, 2019 | Audited Results & Dividend | - |
| Jan 25, 2019 | Quarterly Results | - |
| Oct 29, 2018 | Quarterly Results | - |
| Aug 01, 2018 | Quarterly Results | - |
| May 10, 2018 | Audited Results & Dividend | - |
| Feb 13, 2018 | Quarterly Results | - |
| Nov 04, 2017 | Quarterly Results | - |
| Aug 12, 2017 | Quarterly Results | - |
| May 10, 2017 | Audited Results & Dividend | - |
| Mar 29, 2017 | Others | Approved allotment of 4,41,13,440 fully paid Bonus Equity Shares of Rs. 5 each (Rs. Five) in the ratio of 1:1 (i.e. 1 (One) new equity bonus shares of Rs. 5 each for every 1 (one) existing fully paid |
| Feb 06, 2017 | Qtr Results, Bonus & Interim Dividend | To consider the issue of Bonus Shares, subject to approval of shareholdeis to be obtained in this behalf. |
| Nov 09, 2016 | Quarterly Results & Interim Dividend | - |
| Aug 08, 2016 | Quarterly Results | - |
| May 13, 2016 | Audited Results & Final Dividend | - |
| Mar 10, 2016 | Interim Dividend | - |
| Feb 04, 2016 | Quarterly Results | - |
| Oct 27, 2015 | Quarterly Results | - |
| Jul 31, 2015 | Quarterly Results | - |
| May 04, 2015 | Audited Results & Dividend | - |
| Feb 04, 2015 | Quarterly Results | - |
| Nov 05, 2014 | Quarterly Results | - |
| Jul 30, 2014 | Quarterly Results | - |
| May 15, 2014 | Audited Results & Final Dividend | - |
| Jan 25, 2014 | Quarterly Results | - |
| Oct 28, 2013 | Quarterly Results | - |
| Jul 31, 2013 | Quarterly Results | - |
| May 13, 2013 | Audited Results & Dividend | - |
| Feb 09, 2013 | Quarterly Results | - |
| Oct 29, 2012 | Quarterly Results | - |
| Jul 31, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results & Dividend | (Revised) |
| Jan 30, 2012 | Quarterly Results | (Revised) |
| Oct 24, 2011 | Quarterly Results | - |
| Jul 30, 2011 | Quarterly Results | - |
| May 22, 2011 | Audited Results & Dividend | - |
| Jan 29, 2011 | Quarterly Results | - |
| Oct 22, 2010 | Quarterly Results | - |
| Jul 31, 2010 | Quarterly Results | - |
| May 17, 2010 | Audited Results & Dividend | - |
| Mar 17, 2010 | To consider allotment of bonus shares | To consider the results of postal ballot process and fix the record date for the purpose of allotment of bonus shares. |
| Feb 09, 2010 | Bonus Issue | The BoD's has approved the Bonus Shares in proportion of One new Equity Share of Rs. 10/- each for every one existing Equity Shares of Rs. 10/- each held by the Shareholders. |
| Jan 23, 2010 | Quarterly Results | - |
| Oct 26, 2009 | Quarterly Results | - |
| Jul 31, 2009 | Quarterly Results | - |
| May 30, 2009 | Audited Results & Dividend | - |
| Jan 31, 2009 | Quarterly Results | - |
| Oct 25, 2008 | Quarterly Results | - |
| Jul 29, 2008 | Quarterly Results | - |
| May 20, 2008 | Audited Results & Dividend | - |
| Jan 22, 2008 | Quarterly Results | - |
| Oct 29, 2007 | Allotment of Equity Shares | The Board has allotted 1,06,250 Equity Shares of Rs. 10/- each credited as fully paid-up on payment of Rs. 106/- per Share including Rs. 96/- as premium. |
| Jul 27, 2007 | Quarterly Results | - |
| May 26, 2007 | Audited Results & Dividend | - |
| Mar 17, 2007 | Allotment of Convertible Warrants | The Board has allotted 4,25,000 Warrants Convertible into equal number of Equity Shares to the Promoters / Promoter Group. |
| Jan 25, 2007 | Quarterly Results | - |
| Oct 28, 2006 | Quarterly Results | - |
| Jul 31, 2006 | Quarterly Results | - |
| May 26, 2006 | Accounts & Others | To consider the proposal to issue preference shares to promoter(s) and strategic partners. |
| Jan 27, 2006 | Quarterly Results | - |
| Oct 28, 2005 | Quarterly Results | - |
| Jul 28, 2005 | Quarterly Results | - |
| May 26, 2005 | Accounts | - |
| Jan 27, 2005 | Quarterly Results | - |
| Dec 20, 2004 | Others | Approved the sale of 113400 forfeited equity shares. |
| Oct 31, 2004 | Quarterly Results | - |
| Jun 11, 2004 | Dividend & Accounts | - |
| May 04, 2004 | Others | To consider forfeiture of partly paid equity shares of the company. |
| Mar 13, 2004 | Others | To consider foreiture of partly paid Equity shares. |
| Jan 27, 2004 | Quarterly Results | - |
| Oct 27, 2003 | Quarterly Results | - |
| Jul 31, 2003 | Quarterly Results | - |
| Jun 30, 2003 | Accounts | - |
| Jan 23, 2003 | Quarterly Results | - |
| Oct 26, 2002 | Quarterly Results | - |
| Jul 27, 2002 | Quarterly Results | - |
| Jun 18, 2002 | Accounts | - |
| Jan 28, 2002 | Quarterly Results | - |
| Oct 31, 2001 | Quarterly Results | - |
| Jul 28, 2001 | Quarterly Results | - |
| Jun 27, 2001 | Accounts | - |
| Jan 18, 2001 | Quarterly Results | - |
| Oct 31, 2000 | Quarterly Results | - |
| Jul 15, 2000 | Quarterly Results | - |
| Jan 29, 2000 | Quarterly Results | - |
| Oct 29, 1999 | Quarterly Results | - |
| Jul 24, 1999 | Quarterly Results | - |
| May 31, 1999 | Accounts | - |
| Jan 30, 1999 | Quarterly Results | - |
| Jun 29, 1998 | Accounts | - |
| Nov 29, 1997 | Half Yearly Results | - |
| Jul 10, 1997 | Accounts | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Mar 24, 2017 | 1:1 | 2017-03-28 |
| Jul 09, 2013 | 1:1 | 2013-07-10 |
| Mar 26, 2010 | 1:1 | 2010-03-29 |
04 Jul 2024
POLY MEDICURE LTD. - 531768 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Regualtion 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached Postal Ballot Notice dated June, 29, 2024, seeking approval of the members of the Company, only by way of remote e-voting process for the Resolution as stated therin.
02 Jul 2024
POLY MEDICURE LTD. - 531768 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jai Polypan Pvt Ltd
29 Jun 2024
POLY MEDICURE LTD. - 531768 - Closure of Trading Window
It may pleased noted that in compliance with Company''s code of conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Monday, the 01st July, 2024 till the end of 48 hours after the declaration of financial results for the quarter ended on 30th June, 2024.
29 Jun 2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placement
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to inform the stock exchange that Board of Directors at their meeting held today i.e. 29th June, 2024, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, has considered and approved the proposal for raising of funds through issuance of new securities by way Qualified Institutional Placement ("QIP") and seeking approval of the members by way of Special Resolution for the same and in this regard we wish to submit as under:- a) The Board has considered and approved raising of funds to the tune of amount not exceeding INR 1,000 Crore (One Thousand Crore) through new issue of equity shares by way of qualified institutions placement, in accordance with the relevant provisions of applicable law and subject to approval of the Company''s shareholders and receipt of applicable regulatory approvals.
29 Jun 2024
POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On Today I.E. 29Th June, 2024 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 29th June, 2024, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase -III, New Delhi- 110020, has considered and approved the proposal for raising of funds through issuance of new securities by way Qualified Institutional Placement ('QIP') and seeking approval of the members by way of Special Resolution for the same and in this regard we wish to submit as under :- a) The Board has considered and approved raising of funds to the tune of amount not exceeding INR 1,000 Crore (One Thousand Crore) through new issue of equity shares by way of qualified institutions placement, in accordance with the relevant provisions of applicable law and subject to approval of the Company''s shareholders and receipt of applicable regulatory approvals.
28 Jun 2024
POLY MEDICURE LTD. - 531768 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jai Polypan Pvt Ltd & Others
25 Jun 2024
POLY MEDICURE LTD. - 531768 - Closure of Trading Window
Pursuant to Regulation 29(1) and 29(2) of SEBI(LODR) Regulations, 2015, in continuation with our Board Meeting held on 08th March, 2024 in which Board has approved raising of funds, intimation is hereby given that a Meeting of Board of Directors is scheduled to be held on Saturday, the 29th June, 2024, inter alia to consider and finalize the terms and condition and approve the modes of fund raising, Further in accordance with the SEBI(Prohibition of Insider Trading) Regulations, 2015 and the Company''s code of conduct for prevention of Insider Trading, the Trading Window for dealings in Company''s securities will be closed till further notice.
25 Jun 2024
POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Notice Of Closure Of Trading Window
POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) and 29(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in continuation with our Board Meeting held on 08th March, 2024 in which Board has approved Raising of funds, intimation is hereby given that a Meeting of Board of Directors is scheduled to be held on Saturday, the 29th June, 2024, inter alia to consider and finalize the terms and condition and approve the modes of fund raising. Further, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s code of Conduct for Prevention of Insider Trading, the Trading Window for dealings in the Company''s securities will be closed till further notice. The Board would also consider convening an extra-ordinary general meeting/ postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal of fund raising, as required.
21 Jun 2024
Poly Medicure Shareholder Divests Stake For Rs 443.82 Crore
Mumbai-based Lighthouse Advisors India through its affiliateLighthouse India III Equity Investorsoffloaded 22.76 lakh shares at Rs 1,950.03 apiece.
24 May 2024
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
pursuant to Regulation 30(6) of SEBI(LODR) Regulations, 2015, we hereby submit transcript of the investor Meet/Call held on 20th May, 2024, on the Audited Financial Results of the Company for the quarter and year ended on 31st March , 2024, on standalone and consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 17th May, 2024.
